Patent ID: 9738878
Date: 2017-08-22
CPC Classifications: A61K,A61P,C07K,C12N,C12Y

Claim:
1. A method for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection or Acquired Immune Deficiency Syndrome (AIDS), comprising administering to a subject in need thereof a pharmaceutical composition comprising at least one peptide selected from the group consisting of: a peptide consisting of the sequence GSNFTSTTVKA (SEQ ID NO:2); a peptide consisting of the sequence TAVQMAVFIHNFKRK (SEQ ID NO:3); a peptide consisting of the sequence THLEGKIILVAVHVA (SEQ ID NO:4); a peptide consisting of the sequence WGSNFTSTTVKA (SEQ ID NO:5); a peptide consisting of the sequence WTAVQMAVFIHNFKRK (SEQ ID NO:6); and a peptide consisting of the sequence WTHLEGKIILVAVHVA (SEQ ID NO:7).